[在呼吸道过敏疾病中对过敏原成分解决诊断的研究进展]
1Department of Pediatrics, Suzhou Science & Technology Town Hospital/Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou 215153, China Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
|September 24, 2023
概括
组件解决诊断 (CRD) 为过敏性疾病提供了精确的过敏原检测. 这种分子技术有助于精确评估,预防和治疗呼吸道过敏.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 分子诊断学 分子诊断
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性疾病对全球健康构成重大负担.
- 准确的诊断对于有效的管理和治疗策略至关重要.
- 传统的过敏测试可能在识别致病过敏原时缺乏特异性.
研究的目的:
- 引入过敏原组件解决诊断 (CRD) 技术.
- 审查CRD在呼吸道过敏疾病中的研究进展.
- 讨论CRD在呼吸道过敏的精确预防和治疗中的重要性.
主要方法:
- 关于过敏原成分解决诊断的当前文献的综述.
- 分析CRD的应用和呼吸道过敏研究的进展.
- 讨论CRD在过敏呼吸道疾病临床决策中的作用.
主要成果:
- CRD提供了对过敏原成分的详细蛋白质概况.
- 这项技术可以准确识别特定的过敏原.
- CRD在了解和管理呼吸道过敏方面具有显著价值.
结论:
- 过敏原成分解决诊断是一种有价值的分子诊断工具.
- CRD提高了过敏患者对过敏原检测的精度.
- 在精确评估,预防和治疗呼吸道过敏疾病方面,CRD起着至关重要的作用.
相关概念视频
Allergic Reactions
27.7K
Overview
27.7K
Drugs Used in Lower Respiratory Disorders: Overview
474
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
474
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


